KNSA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 54.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $10,095,787.61

Kiniksa Pharmaceuticals Insider Trading History Chart

Kiniksa Pharmaceuticals Share Price & Price History

^$20.05

▼ -0.16 (-0.79%)

As of 04/21/2025 05:00 PM ET

Days: 30 | 90 | 365

Kiniksa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/14/2025	Eben Tessari	COO	Sell	12,000	$20.48	$245,760.00	77,363
3/19/2025	Mark Ragosa	CFO	Sell	8,879	$23.10	$205,104.90	23,382
3/17/2025	Mark Ragosa	CFO	Sell	11,464	$23.10	$264,818.40	23,382
3/12/2025	Mark Ragosa	CFO	Sell	36,372	$22.25	$809,277.00	22,958
3/12/2025	Michael R. Megna	CAO	Sell	9,051	$22.45	$203,194.95	26,528
2/10/2025	Eben Tessari	COO	Sell	14,000	$19.57	$273,980.00	81,975
1/13/2025	Eben Tessari	COO	Sell	14,000	$18.24	$255,360.00	88,975
12/5/2024	Mark Ragosa	CFO	Sell	1,123	$21.25	$23,863.75	22,958
12/3/2024	Mark Ragosa	CFO	Sell	8,969	$21.45	$192,385.05	22,958
10/15/2024	Eben Tessari	COO	Sell	17,000	$26.87	$456,790.00	109,975
9/23/2024	Eben Tessari	COO	Sell	17,500	$24.99	$437,325.00	116,975
9/3/2024	John F. Paolini	Insider	Sell	60,692	$26.12	$1,585,275.04	52,038
8/27/2024	Eben Tessari	COO	Sell	17,500	$26.91	$470,925.00	119,911
7/23/2024	John F. Paolini	Insider	Sell	22,000	$26.32	$579,040.00	47,803
7/23/2024	Mark Ragosa	CFO	Sell	24,248	$24.79	$601,107.92	19,253
7/23/2024	Sanj K. Patel	CEO	Sell	136,124	$25.65	$3,491,580.60	63,012
3/6/2024	Sanj K. Patel	CEO	Sell	5,582	$21.00	$117,222.00	65,012
3/4/2024	Sanj K. Patel	CEO	Sell	12,742	$21.49	$273,825.58	70,594
3/1/2024	Michael R. Megna	CAO	Sell	9,659	$21.45	$207,185.55	17,588
2/28/2024	Michael R. Megna	CAO	Sell	5,126	$21.79	$111,695.54	17,588
1/3/2024	Mark Ragosa	CFO	Sell	12,000	$20.00	$240,000.00	15,632
1/2/2024	Michael R. Megna	CAO	Sell	16,670	$19.17	$319,563.90	17,005
12/19/2023	Michael R. Megna	CAO	Sell	9,316	$19.13	$178,215.08	17,005
12/7/2023	John F. Paolini	Insider	Sell	28,600	$17.65	$504,790.00	44,892
9/5/2023	John F. Paolini	Insider	Sell	400	$17.53	$7,012.00	44,892
7/25/2023	John F. Paolini	Insider	Sell	29,000	$19.14	$555,060.00	41,910
11/29/2022	Barry D. Quart	Director	Sell	21,959	$16.15	$354,637.85

See Full Table

SEC Filings (Institutional Ownership Changes) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

53.95% of Kiniksa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kiniksa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2025	Wealth Enhancement Advisory Services LLC	13,564	$0.30M	0.0%	N/A	0.019%
4/15/2025	GAMMA Investing LLC	1,238	$27K	0.0%	+84.8%	0.002%
4/10/2025	Hennion & Walsh Asset Management Inc.	184,126	$4.09M	0.2%	-7.7%	0.253%
4/8/2025	Rhumbline Advisers	62,700	$1.39M	0.0%	+6.4%	0.086%
4/7/2025	GAMMA Investing LLC	27,496	$0.61M	0.0%	+4,003.9%	0.038%
3/24/2025	Wellington Management Group LLP	69,813	$1.38M	0.0%	+46.3%	0.096%
3/18/2025	California State Teachers Retirement System	34,322	$0.68M	0.0%	-9.8%	0.047%
2/27/2025	Jefferies Financial Group Inc.	112,400	$2.22M	0.0%	+39.5%	0.156%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	56,691	$1.12M	0.0%	+28.2%	0.079%
2/17/2025	Voloridge Investment Management LLC	140,878	$2.79M	0.0%	-25.8%	0.195%
2/17/2025	Woodline Partners LP	19,005	$0.38M	0.0%	-44.2%	0.026%
2/17/2025	Squarepoint Ops LLC	26,808	$0.53M	0.0%	N/A	0.037%
2/17/2025	State of Wyoming	14,806	$0.29M	0.0%	N/A	0.021%
2/17/2025	ProShare Advisors LLC	12,807	$0.25M	0.0%	+35.5%	0.018%
2/17/2025	Parkman Healthcare Partners LLC	765,453	$15.14M	2.0%	+1.4%	1.060%
2/17/2025	Nuveen Asset Management LLC	795,612	$15.74M	0.0%	+7.3%	1.102%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	99,632	$1.97M	0.2%	+32.5%	0.138%
2/17/2025	Millennium Management LLC	779,672	$15.42M	0.0%	+50.9%	1.080%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	21,841	$0.43M	0.0%	+6.7%	0.030%
2/17/2025	Lazard Asset Management LLC	3,098	$61K	0.0%	N/A	0.004%
2/17/2025	Lion Point Capital LP	45,900	$0.91M	4.8%	-25.2%	0.064%
2/17/2025	Jefferies Financial Group Inc.	112,400	$2.22M	0.0%	+39.5%	0.156%
2/17/2025	Hudson Bay Capital Management LP	225,000	$4.45M	0.0%	+150.0%	0.312%
2/17/2025	Granahan Investment Management LLC	463,110	$9.16M	0.4%	-8.7%	0.641%
2/17/2025	Fairmount Funds Management LLC	2,194,341	$43.40M	4.3%	-31.5%	3.039%
2/17/2025	Deutsche Bank AG	142,397	$2.82M	0.0%	+77.3%	0.197%
2/17/2025	D. E. Shaw & Co. Inc.	320,007	$6.33M	0.0%	-0.3%	0.443%
2/17/2025	Driehaus Capital Management LLC	613,550	$12.14M	0.1%	-16.1%	0.850%
2/17/2025	Braidwell LP	3,452,447	$68.29M	2.0%	+19.3%	4.782%
2/17/2025	Balyasny Asset Management L.P.	12,921	$0.26M	0.0%	N/A	0.018%
2/17/2025	Bellevue Group AG	8,100	$0.16M	0.0%	N/A	0.011%
2/17/2025	Bank of America Corp DE	215,772	$4.27M	0.0%	+2.2%	0.299%
2/17/2025	BNP Paribas Financial Markets	173,480	$3.43M	0.0%	-10.1%	0.240%
2/17/2025	Ameriprise Financial Inc.	51,076	$1.01M	0.0%	-70.9%	0.071%
2/17/2025	Algert Global LLC	135,814	$2.69M	0.1%	+49.0%	0.188%
2/17/2025	ArrowMark Colorado Holdings LLC	521,889	$10.32M	0.1%	-1.8%	0.723%
2/14/2025	Jane Street Group LLC	189,452	$3.75M	0.0%	-45.1%	0.262%
2/14/2025	PDT Partners LLC	64,917	$1.28M	0.1%	+74.3%	0.090%
2/14/2025	Schonfeld Strategic Advisors LLC	28,400	$0.56M	0.0%	-68.2%	0.039%
2/14/2025	Northern Trust Corp	283,599	$5.61M	0.0%	+11.1%	0.393%
2/14/2025	Nebula Research & Development LLC	29,521	$0.58M	0.1%	-24.3%	0.041%
2/14/2025	Oberweis Asset Management Inc.	237,200	$4.69M	0.2%	+18.0%	0.329%
2/14/2025	Voya Investment Management LLC	19,988	$0.40M	0.0%	+16.8%	0.028%
2/14/2025	Price T Rowe Associates Inc. MD	15,111	$0.30M	0.0%	+23.6%	0.021%
2/14/2025	Hsbc Holdings PLC	13,112	$0.26M	0.0%	-4.1%	0.018%
2/14/2025	Tower Research Capital LLC TRC	8,483	$0.17M	0.0%	+117.1%	0.012%
2/14/2025	MetLife Investment Management LLC	23,095	$0.46M	0.0%	+6.3%	0.032%
2/14/2025	Dimensional Fund Advisors LP	771,607	$15.26M	0.0%	+3.9%	1.069%
2/13/2025	Marshall Wace LLP	86,762	$1.72M	0.0%	-4.2%	0.120%
2/13/2025	Jump Financial LLC	14,601	$0.29M	0.0%	-68.0%	0.020%
2/13/2025	Barclays PLC	71,896	$1.42M	0.0%	+11.2%	0.100%
2/13/2025	Raymond James Financial Inc.	199,953	$3.96M	0.0%	N/A	0.277%
2/13/2025	Martingale Asset Management L P	49,360	$0.98M	0.0%	+1.9%	0.068%
2/13/2025	Legal & General Group Plc	41,267	$0.82M	0.0%	-18.0%	0.057%
2/13/2025	Invesco Ltd.	14,108	$0.28M	0.0%	-74.6%	0.020%
2/13/2025	ADAR1 Capital Management LLC	166,406	$3.29M	0.7%	-61.9%	0.230%
2/13/2025	Cerity Partners LLC	28,598	$0.57M	0.0%	-14.3%	0.040%
2/13/2025	Wells Fargo & Company MN	21,102	$0.42M	0.0%	+54.7%	0.029%
2/12/2025	ExodusPoint Capital Management LP	127,161	$2.52M	0.0%	+965.2%	0.176%
2/12/2025	Massachusetts Financial Services Co. MA	64,881	$1.28M	0.0%	-2.9%	0.090%
2/12/2025	Trexquant Investment LP	80,842	$1.60M	0.0%	-47.9%	0.112%
2/12/2025	Geode Capital Management LLC	492,630	$9.74M	0.0%	+2.0%	0.682%
2/12/2025	Wellington Management Group LLP	69,813	$1.38M	0.0%	+46.3%	0.097%
2/12/2025	Arrowstreet Capital Limited Partnership	22,453	$0.44M	0.0%	-86.1%	0.031%
2/12/2025	Pictet Asset Management Holding SA	1,133,931	$22.43M	0.0%	-6.1%	1.570%
2/12/2025	JPMorgan Chase & Co.	477,800	$9.45M	0.0%	+138.9%	0.662%
2/11/2025	Prudential Financial Inc.	91,920	$1.82M	0.0%	-22.6%	0.127%
2/11/2025	Corebridge Financial Inc.	15,430	$0.31M	0.0%	-5.0%	0.021%
2/11/2025	Advantage Alpha Capital Partners LP	8,890	$0.18M	0.0%	-56.4%	0.012%
2/11/2025	Vanguard Group Inc.	3,207,497	$63.44M	0.0%	-2.8%	4.443%
2/11/2025	KLP Kapitalforvaltning AS	8,000	$0.16M	0.0%	N/A	0.011%
2/11/2025	Knights of Columbus Asset Advisors LLC	60,966	$1.21M	0.1%	-16.2%	0.084%
2/11/2025	Sei Investments Co.	42,184	$0.83M	0.0%	-5.3%	0.058%
2/11/2025	Teacher Retirement System of Texas	10,862	$0.22M	0.0%	+7.1%	0.015%
2/10/2025	Globeflex Capital L P	88,596	$1.75M	0.1%	+217.1%	0.123%
2/10/2025	Swiss National Bank	71,900	$1.42M	0.0%	-8.5%	0.100%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	306,946	$6.07M	0.0%	-5.3%	0.425%
2/7/2025	Essex Investment Management Co. LLC	173,799	$3.44M	0.6%	-13.3%	0.241%
2/6/2025	Raymond James Financial Inc.	199,953	$3.96M	0.0%	N/A	0.277%
2/6/2025	Arizona State Retirement System	10,607	$0.21M	0.0%	-8.9%	0.015%
2/6/2025	Charles Schwab Investment Management Inc.	122,019	$2.41M	0.0%	+36.1%	0.169%
2/4/2025	Los Angeles Capital Management LLC	55,528	$1.10M	0.0%	-44.5%	0.077%
2/4/2025	Bank of New York Mellon Corp	122,051	$2.41M	0.0%	+33.1%	0.169%
2/4/2025	Y Intercept Hong Kong Ltd	13,050	$0.26M	0.0%	N/A	0.018%
1/31/2025	New York State Common Retirement Fund	15,248	$0.30M	0.0%	+12.4%	0.021%
1/31/2025	Rice Hall James & Associates LLC	642,752	$12.71M	0.7%	-1.1%	0.890%
1/31/2025	Peregrine Capital Management LLC	244,043	$4.83M	0.1%	+1.8%	0.338%
1/31/2025	Principal Financial Group Inc.	26,907	$0.53M	0.0%	-49.1%	0.037%
1/30/2025	Rhumbline Advisers	58,955	$1.17M	0.0%	-1.5%	0.082%
1/29/2025	Legato Capital Management LLC	51,379	$1.02M	0.1%	-23.4%	0.071%
1/29/2025	Allspring Global Investments Holdings LLC	49,309	$0.98M	0.0%	-14.4%	0.068%
1/24/2025	China Universal Asset Management Co. Ltd.	8,814	$0.17M	0.0%	+12.9%	0.012%
1/17/2025	SG Americas Securities LLC	17,970	$0.36M	0.0%	N/A	0.025%
1/15/2025	Hennion & Walsh Asset Management Inc.	199,525	$3.95M	0.2%	+1.9%	0.276%
1/6/2025	Nordea Investment Management AB	194,883	$3.82M	0.0%	+4.4%	0.270%
12/26/2024	JPMorgan Chase & Co.	199,973	$5M	0.0%	N/A	0.277%
12/19/2024	Principal Financial Group Inc.	52,851	$1.32M	0.0%	-21.1%	0.073%
11/27/2024	Franklin Resources Inc.	67,533	$1.80M	0.0%	+1.7%	0.094%
11/16/2024	Geode Capital Management LLC	482,976	$12.07M	0.0%	-43.1%	0.669%
11/15/2024	M&T Bank Corp	30,735	$0.77M	0.0%	-15.5%	0.043%

Data available starting January 2016

See Full Table

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was incorporated in 2015 and is based in Hamilton, Bermuda.

Today's Range

Now: $20.05

$19.90

$20.89

50 Day Range

MA: $21.05

$18.65

$23.81

52 Week Range

Now: $20.05

$16.87

$28.15

Volume

658,920 shs

Average Volume

464,078 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top insider shareholders include:
Eben Tessari (COO)
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More about top insider investors at Kiniksa Pharmaceuticals.
Who are the major institutional investors of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.25%
Rhumbline Advisers — 0.09%
GAMMA Investing LLC — 0.04%
Wealth Enhancement Advisory Services LLC — 0.02%
GAMMA Investing LLC — 0.00%
Learn More about top institutional investors of Kiniksa Pharmaceuticals stock.
Which major investors are selling Kiniksa Pharmaceuticals stock?: During the last quarter, KNSA stock was sold by these institutional investors:
Hennion & Walsh Asset Management Inc.
During the previous year, company insiders that have sold Kiniksa Pharmaceuticals company stock include:
Eben Tessari (COO)
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More investors selling Kiniksa Pharmaceuticals stock.
Which major investors are buying Kiniksa Pharmaceuticals stock?: In the previous quarter, KNSA stock was bought by institutional investors including:
GAMMA Investing LLC
Wealth Enhancement Advisory Services LLC
Rhumbline Advisers
GAMMA Investing LLC